Giuseppe Curigliano
Division of Medical Oncology
Istituto Europeo di Oncologia
Via Ripamonti 435
20141 Milano
Name/email consistency: high
- Targeting the subtypes of breast cancer: rethinking investigational drugs. Curigliano, G., Locatelli, M., Fumagalli, L., Brollo, J., Munzone, E., Nolé, F., Criscitiello, C., Goldhirsch, A. Expert. Opin. Investig. Drugs (2012)
- Cancer-testis antigen expression in triple-negative breast cancer. Curigliano, G., Viale, G., Ghioni, M., Jungbluth, A.A., Bagnardi, V., Spagnoli, G.C., Neville, A.M., Nolè, F., Rotmensz, N., Goldhirsch, A. Ann. Oncol. (2011)
- The triple-negative subtype: new ideas for the poorest prognosis breast cancer. Curigliano, G., Goldhirsch, A. J. Natl. Cancer Inst. Monographs (2011)
- Cardiac toxicity from systemic cancer therapy: a comprehensive review. Curigliano, G., Mayer, E.L., Burstein, H.J., Winer, E.P., Goldhirsch, A. Prog. Cardiovasc. Dis (2010)
- Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer. Curigliano, G., Viale, G., Bagnardi, V., Fumagalli, L., Locatelli, M., Rotmensz, N., Ghisini, R., Colleoni, M., Munzone, E., Veronesi, P., Zurrida, S., Nolè, F., Goldhirsch, A. J. Clin. Oncol. (2009)
- Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study. Curigliano, G., Spitaleri, G., Magni, E., Lorizzo, K., De Cobelli, O., Locatelli, M., Fumagalli, L., Adamoli, L., Cossu Rocca, M., Verri, E., De Pas, T., Jereczek-Fossa, B., Martinelli, G., Goldhirsch, A., Nolè, F. J. Chemother (2009)
- Immunizing against breast cancer: a new swing for an old sword. Curigliano, G., Locatelli, M., Fumagalli, L., Goldhirsch, A. Breast (2009)
- Drug-induced QTc interval prolongation: a proposal towards an efficient and safe anticancer drug development. Curigliano, G., Spitaleri, G., Fingert, H.J., de Braud, F., Sessa, C., Loh, E., Cipolla, C., De Pas, T., Goldhirsch, A., Shah, R. Eur. J. Cancer (2008)
- Immunology and breast cancer: therapeutic cancer vaccines. Curigliano, G., Rescigno, M., Goldhirsch, A. Breast (2007)
- Gefitinib combined with endocrine manipulation in patients with hormone-refractory prostate cancer: quality of life and surrogate markers of activity. Curigliano, G., De Braud, F., Teresa Sandri, M., Renne, G., Zorzino, L., Scardino, E., Rocco, B., Spitaleri, G., De Pas, T., Noberasco, C., Nolè, F., Verweij, F., Matei, V., De Cobelli, O. Anticancer. Drugs (2007)
- Vaccine immunotherapy in breast cancer treatment: promising, but still early. Curigliano, G., Spitaleri, G., Dettori, M., Locatelli, M., Scarano, E., Goldhirsch, A. Expert. Rev. Anticancer. Ther (2007)
- Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib. Curigliano, G., Pelosi, G., De Pas, T., Renne, G., De Cobelli, O., Manzotti, M., Spitaleri, G., de Braud, F. Prostate (2007)
- Breast cancer vaccines: a clinical reality or fairy tale?. Curigliano, G., Spitaleri, G., Pietri, E., Rescigno, M., de Braud, F., Cardillo, A., Munzone, E., Rocca, A., Bonizzi, G., Brichard, V., Orlando, L., Goldhirsch, A. Ann. Oncol. (2006)
- Adjuvant therapy for very young women with breast cancer: response according to biologic and endocrine features. Curigliano, G., Rigo, R., Colleoni, M., Braud, F.D., Nole, F., Formica, V., Orlando, L., Cinieri, S., Torrisi, R., Cardillo, A., Peruzzotti, G., Medici, M., Ardito, R., Minchella, I., Goldhirsch, A. Clin. Breast Cancer (2004)
- Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay. Curigliano, G., Colleoni, M., Renne, G., Mazzarol, G., Gennari, R., Peruzzotti, G., de Braud, E., Robertson, C., Maiorano, E., Veronesi, P., Nolè, F., Mandalà, M., Ferretti, G., Viale, G., Goldhirsch, A. Ann. Oncol. (2002)
- Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis. Curigliano, G., Ferretti, G., Flamini, G., Goldhirsch, A., de Braud, F., Calabro, M.G., Mandaly, M., Nole, F., De Pas, T., D'Addessi, A., Cittadini, A. Anticancer Res. (2001)
- GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis. Curigliano, G., Ferretti, G., Mandalà, M., De Pas, T., Calabrò, M.G., Solli, P., Noberasc, C., de Braud, F. Anticancer Res. (2001)